BDMD - CIK 0001982444
Baird Medical Investment Holdings Ltd trades as BDMD. In its fiscal 2025 annual report the company posted revenue of $22.54M, down 39.2% from the prior year and net income of -$27.28M. This page tracks Baird Medical Investment Holdings Ltd through 68 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin compressed from 33.5% to -121.0% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| POS AM | - | 2026-05-22 |
| F-3 | - | 2026-05-22 |
| SCHEDULE 13G | - | 2026-05-08 |
| 20-F | - | 2026-04-24 |
| New insider ownership | 3 | 2026-04-21 |
| New insider ownership | 3 | 2026-04-21 |
| New insider ownership | 3 | 2026-04-21 |
| New insider ownership | 3 | 2026-04-17 |
The largest companies sharing Baird Medical Investment Holdings Ltd's SEC industry classification (surgical & medical instruments & apparatus).
Baird Medical Investment Holdings Ltd reported revenue of $22.54M for fiscal year 2025, a decrease of 39.2% year over year.
In its latest fiscal year Baird Medical Investment Holdings Ltd reported a net loss of $27.28M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.